Chancellor extends British Patient Capital mandate to 2033
British Patient Capital will continue backing later-stage UK companies up until 2033 after the government extended its mandate in the Spring Statement. It extends British...
Category : British Patient Capital
Pfizer Ventures co-leads £40m funding in Grey Wolf Therapeutics
The corporate venture capital arm of Covid-19 vaccine maker Pfizer has co-led a $49m (£39.6m) investment into Oxford-based biotech startup Grey Wolf, which develops immuno-oncology...
Medical imaging company Perspectum raises £30m
Precision health technology company Perspectum has closed $36m (£30.4m) in its first round of Series C funding, led by Oppenheimer Holdings. Oxford headquartered Perspectum provides...
UK VCs face dwindling exit opportunities, report finds
VCs and startups are grappling with tough conditions to raise capital and find exit opportunities, a report has found. Nearly three-quarters of fund managers surveyed...
Startup using machine learning to find new medicines raises £38m
Biotech startup Nucleome Therapeutics has raised £37.5m in an oversubscribed Series A round to discover new medicines by decoding the human genome. The investment will...
Bioinformatics platform Microbiotica raises £50m to conduct clinical trials
Microbiotica, a healthtech company that has created a platform to develop personalised medicines, has secured £50m in a Series B funding round led by Flerie...
